Sebaceous hyperplasia removal — treating small yellowish bumps on the face

Key facts

• Enlarged oil glands, not acne or milia
• Often yellowish with a small central dip
• Can mimic basal cell carcinoma — examination matters
• Options: CO2 laser, cautery, shave, topical retinoids
• Tendency can persist, so new bumps may appear

What sebaceous hyperplasia is

Sebaceous glands produce the skin’s natural oil. In sebaceous hyperplasia, some glands become enlarged and form small bumps, usually 2–4 mm, that are soft, flesh-coloured to yellow and often have a small central depression where the gland opens. Fine blood vessels may be visible around the edge. The condition is common from middle age onwards and is more frequent in people with oily skin, a family tendency, long-term sun exposure and in some people taking certain medications such as ciclosporin. It is benign, not contagious and not a form of acne. Because the bumps are gland tissue rather than trapped material, squeezing does not remove them and may cause bruising or marks.

Why diagnosis matters

Sebaceous hyperplasia can look similar to an early basal cell carcinoma, the most common skin cancer, which may also appear as a pearly bump with small surface vessels. It can also resemble milia, small cysts, xanthelasma or other adnexal growths. Dr. Abdullah Anis examines the lesions with dermoscopy, which typically shows a characteristic pattern of yellowish lobules with vessels around the outside in sebaceous hyperplasia. Any lesion that is solitary and growing, bleeds, ulcerates or does not have the typical features may be biopsied for histology. His fellowship in dermatopathology adds experience in correlating what is seen on the skin with what the laboratory finds.

Treatment options

Treatment is optional and done for cosmetic reasons once the bumps are confirmed benign. Options the dermatologist may discuss include precise CO2 laser ablation of each bump, electrocautery, gentle shave removal, or topical retinoids that can make lesions less prominent and reduce new ones over time. Chemical peels may play a supporting role. Each approach balances how completely the gland is treated against the risk of small indented scars or pigment change, which is particularly relevant in medium and darker skin types. The doctor will explain which method suits your skin, how many sessions may be needed and what the healing period usually looks like.

Healing and recurrence

After laser or cautery, treated spots usually form small crusts that fall off within about a week. Keep them clean, use the recommended ointment, avoid picking and protect the area with sunscreen, as new skin pigments easily in Dubai’s sun. Temporary redness is common. Because the underlying tendency remains, a treated bump can sometimes return and new bumps may form elsewhere over the years. Ongoing use of a prescribed retinoid, if suitable for you, may help reduce recurrence. Many people choose to have a few new lesions treated periodically rather than expecting a one-off cure.

When to seek review and how Manhal can help

Book a dermatology review if a bump is growing, bleeds, crusts repeatedly, looks pearly with prominent vessels or is different from the others, because these features may suggest a basal cell carcinoma rather than sebaceous hyperplasia. Avoid home extraction tools, needles or acids, which can scar the face. At Manhal Medical Center in Dubai, Dr. Abdullah Anis — a specialist dermatologist with more than 25 years of experience — examines the lesions, explains the diagnosis in English or Arabic and plans treatment only once he is confident they are benign.

Most skin tags and moles are harmless, but anything changing should be checked before removal. With a background in dermatopathology, our dermatologist assesses lesions before choosing laser, shave or excision.

Prepared by the Manhal Medical Center editorial team · Updated: 2026-10-18 · Treating specialist: Dr. Abdullah Anis

This page is general information and does not replace a consultation. Suitability, risks and results vary between patients.